Log in
Enquire now
Enara Bio

Enara Bio

TCR-based immunotherapies developer targeting novel dark antigens for cancer patients.

OverviewStructured DataIssuesContributors
Is a
Company
Company
Organization
Organization
B2X
B2B
B2B
0
CEO
‌
Kevin Pojasek
CFO
‌
Dave Watson
Legal Name
Enara Bio Limited
Company Operating Status
Active
Country
United Kingdom
United Kingdom
Crunchbase URL
crunchbase.com/organiz...n/ervaxx
Email Address
info@enarabio.com
Founded Date
2016
Industry
Drug discovery
Drug discovery
Biomedical engineering
Biomedical engineering
Biotechnology
Biotechnology
Engineering
Engineering
Investors
Pfizer Venture Investments
Pfizer Venture Investments
M Ventures
M Ventures
SV Health Investors
SV Health Investors
RA Capital Management
RA Capital Management
Samsara BioCapital
Samsara BioCapital
Latest Funding Round Date
October 3, 2024
Latest Funding Round Amount (USD)
32,500,000
Latest Funding Type
Series B
Series B
LinkedIn URL
@company/ervaxx-limited
Location
Oxfordshire
Oxfordshire
Number of Employees (Ranges)
51 – 200
0
Total Funding Amount (USD)
32,500,000
Twitter URL
@enara_bio
Official Website
enarabio.com

Find more companies like Enara Bio

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.